Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-776,201
Closed -$28.5M 295
2017
Q3
$28.5M Buy
776,201
+39,547
+5% +$1.6M 0.98% 51
2017
Q2
$33.4M Sell
736,654
-21,125
-3% -$932K 1.23% 17
2017
Q1
$32.2M Sell
757,779
-15,913
-2% -$649K 1.21% 23
2016
Q4
$31M Sell
773,692
-28,442
-4% -$1.1M 1.26% 20
2016
Q3
$31.1M Sell
802,134
-15,454
-2% -$583K 1.26% 15
2016
Q2
$28.3M Sell
817,588
-13,702
-2% -$474K 1.19% 33
2016
Q1
$28.7M Buy
+831,290
New +$29M 1.15% 41

Other funds holding HOLX

Renaissance Group's HOLX Position: Q4 2017 in Review

Renaissance Group sold out of Hologic (HOLX) in Q4 2017, closing a stake of 776,201 shares — an estimated $28.5M sold.

Renaissance Group first reported a position in HOLX in Q1 2016 and held it in 7 quarters. The position peaked at $33.4M in Q2 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Renaissance Group reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Renaissance Group sold 776,201 Hologic shares in Q4 2017, an estimated $28.5M.
  • Renaissance Group first reported a position in Hologic in Q1 2016 and held it in 7 quarters.
  • Renaissance Group's Hologic position peaked at $33.4M in Q2 2017.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Renaissance Group's 13F filing for Q4 2017, filed 6 Feb 2018.